These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7865106)

  • 41. Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen.
    Nakafusa Y; Goss JA; Mohanakumar T; Flye MW
    Transplantation; 1993 Apr; 55(4):877-82. PubMed ID: 8475563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection.
    Gupta RK; Jain M; Sharma RK
    Indian J Med Res; 2004 Jan; 119(1):24-7. PubMed ID: 14997990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.
    Kahan BD; Rajagopalan PR; Hall M
    Transplantation; 1999 Jan; 67(2):276-84. PubMed ID: 10075594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
    van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
    Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
    Carstens J; Ozbay A; Tørring C; Hansen HE
    Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The effect of rejection crises and immunosuppressive therapy on the lymphocyte subpopulations of patients after kidney transplantation].
    Kiparski Av; Frei D; Fierz W; Frei G; Uhlschmid G; Largiader F; Binswanger U
    Klin Wochenschr; 1990 Apr; 68(8):408-14. PubMed ID: 1971857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW
    Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Analysis of specific cellular immunity in renal transplant recipients by MLR & CML].
    Seki Y
    Nihon Geka Gakkai Zasshi; 1983 Jun; 84(6):488-99. PubMed ID: 6232457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of specific nonreactivity in human cadaveric renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Tissue Antigens; 1976 May; 7(5):281-90. PubMed ID: 132717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etiology of Early Renal Allograft Dysfunction and Comparison between Dysfunction and Function Group: A Single Center Study.
    Hadiuzzaman KM; Islam SF; Faroque MO; Hossain RM; Munirunnessa M; Selim SI; Morshed M
    Mymensingh Med J; 2017 Oct; 26(4):748-755. PubMed ID: 29208861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.
    Halloran PF; Schlaut J; Solez K; Srinivasa NS
    Transplantation; 1992 Mar; 53(3):550-5. PubMed ID: 1549846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
    Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
    Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The mechanism of donor specific unresponsiveness in renal transplant recipients].
    Okimoto T; Yahata H; Fukuda Y; Dohi K
    Nihon Rinsho Meneki Gakkai Kaishi; 1998 Jun; 21(3):118-28. PubMed ID: 9754014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells.
    Reinke P; Fietze E; Döcke WD; Kern F; Ewert R; Volk HD
    Transplantation; 1994 Jul; 58(1):35-41. PubMed ID: 7913561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
    Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
    Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.
    Woodle ES; Cronin D; Newell KA; Millis JM; Bruce DS; Piper JB; Haas M; Josephson MA; Thistlethwaite JR
    Transplantation; 1996 Oct; 62(7):906-10. PubMed ID: 8878382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term renal function in type I diabetics after kidney or kidney-pancreas transplantation: influence of number, timing, and treatment of acute rejection episodes.
    Hricik DE; Phinney MS; Weigel KA; Knauss TC; Schulak JA
    Transplantation; 1997 Nov; 64(9):1283-8. PubMed ID: 9371669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tolerance in a concordant nonhuman primate model.
    Bartholomew AM; Powelson J; Sachs DH; Bailin M; Boskovic S; Colvin R; Hong HZ; Johnson M; Kimikawa M; LeGuern A; Meehan S; Sablinski T; Wee SL; Cosimi AB
    Transplantation; 1999 Dec; 68(11):1708-16. PubMed ID: 10609947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.